Stephen Zewinger

2.6k total citations
22 papers, 934 citations indexed

About

Stephen Zewinger is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Stephen Zewinger has authored 22 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Stephen Zewinger's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Stephen Zewinger is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Stephen Zewinger collaborates with scholars based in Germany, Austria and Luxembourg. Stephen Zewinger's co-authors include Thimoteus Speer, Danilo Fliser, Winfried März, Marcus E. Kleber, Hubert Scharnagl, Ulf Landmesser, Vera Jankowski, Sarah Triem, Klaus G. Parhofer and Andreas Ritsch and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Stephen Zewinger

20 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Zewinger Germany 12 317 249 247 191 176 22 934
Kausik Umanath United States 14 655 2.1× 298 1.2× 193 0.8× 164 0.9× 301 1.7× 27 1.4k
Ernesto Martín‐Núñez Spain 18 548 1.7× 224 0.9× 180 0.7× 130 0.7× 310 1.8× 51 1.2k
Christiane Rüster Germany 13 495 1.6× 320 1.3× 128 0.5× 244 1.3× 313 1.8× 21 1.3k
Bryan R. Conway United Kingdom 20 451 1.4× 138 0.6× 171 0.7× 181 0.9× 422 2.4× 41 1.2k
Anna Zdzienicka Poland 16 278 0.9× 152 0.6× 167 0.7× 166 0.9× 261 1.5× 39 980
Junya Jia China 18 405 1.3× 175 0.7× 115 0.5× 189 1.0× 215 1.2× 71 911
Motoshi Ouchi Japan 18 256 0.8× 264 1.1× 183 0.7× 106 0.6× 238 1.4× 58 846
Panai Song China 14 236 0.7× 353 1.4× 279 1.1× 66 0.3× 372 2.1× 27 904
Hiroki Adachi Japan 16 414 1.3× 335 1.3× 210 0.9× 83 0.4× 293 1.7× 74 1.1k

Countries citing papers authored by Stephen Zewinger

Since Specialization
Citations

This map shows the geographic impact of Stephen Zewinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Zewinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Zewinger more than expected).

Fields of papers citing papers by Stephen Zewinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Zewinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Zewinger. The network helps show where Stephen Zewinger may publish in the future.

Co-authorship network of co-authors of Stephen Zewinger

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Zewinger. A scholar is included among the top collaborators of Stephen Zewinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Zewinger. Stephen Zewinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zewinger, Stephen, Tina Rasper, Sebastian Cremer, et al.. (2025). Mosaic loss of Y chromosome and mortality after coronary angiography. European Heart Journal. 46(17). 1603–1616. 7 indexed citations
2.
Abplanalp, Wesley, et al.. (2025). Loss of Y chromosome: proteomic signatures in human cardiovascular disease. European Heart Journal. 46(48). 5237–5239.
3.
Cremer, Sebastian, Tina Rasper, Stephen Zewinger, et al.. (2024). Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease. Circulation. 150(10). 746–757. 18 indexed citations
4.
Nazir, Sumra, et al.. (2020). Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!. Advanced Drug Delivery Reviews. 159. 94–119. 86 indexed citations
5.
Grupp, Clemens, Stephen Zewinger, Bernd Hohenstein, et al.. (2020). Relapsing and Progressive Complications of Severe Hypertriglyceridemia: Effective Long-Term Treatment with Double Filtration Plasmapheresis. Blood Purification. 49(4). 457–467. 15 indexed citations
6.
Silbernagel, Günther, Hubert Scharnagl, Marcus E. Kleber, et al.. (2020). Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease. Atherosclerosis. 311. 84–90. 9 indexed citations
7.
Schunk, Stefan, Alexander Zarbock, Melanie Meersch, et al.. (2019). Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study. The Lancet. 394(10197). 488–496. 113 indexed citations
9.
Zewinger, Stephen, Vera Jankowski, Eunsil Hahm, et al.. (2019). FO084APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION AND ORGAN DAMAGE IN CKD BY ALTERNATIVE INFLAMMASOME ACTIVATION VIA A NOVEL PATHWAY. Nephrology Dialysis Transplantation. 34(Supplement_1). 1 indexed citations
10.
Trudzinski, Franziska, Albert Omlor, Stephen Zewinger, et al.. (2019). Consequences of chronic kidney disease in chronic obstructive pulmonary disease. Respiratory Research. 20(1). 151–151. 37 indexed citations
11.
Vukadinović, Davor, et al.. (2018). Hyperkalaemia in Heart Failure—Pathophysiology, Implications and Therapeutic Perspectives. Current Heart Failure Reports. 15(6). 390–397. 9 indexed citations
12.
Zewinger, Stephen, et al.. (2017). MP177LIPOPROTEIN(A) AND THE RISK OF MORTALITY IN PATIENTS WITH ESTABLISHED CORONARY HEART DISEASE: A PROSPECTIVE STUDY OF 116,548 PATIENTS. Nephrology Dialysis Transplantation. 32(suppl_3). iii493–iii493. 2 indexed citations
13.
März, Winfried, Marcus E. Kleber, Hubert Scharnagl, et al.. (2017). HDL cholesterol: reappraisal of its clinical relevance. Clinical Research in Cardiology. 106(9). 663–675. 180 indexed citations
14.
Silbernagel, Günther, Hubert Scharnagl, Marcus E. Kleber, et al.. (2017). J-shaped association of circulating apolipoprotein C3 with cardiovascular mortality. Atherosclerosis. 263. e89–e90. 1 indexed citations
15.
Holy, Erik W., Alexander Akhmedov, Thimoteus Speer, et al.. (2016). Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1. Journal of the American College of Cardiology. 68(15). 1664–1676. 47 indexed citations
16.
März, Winfried, Marcus E. Kleber, Hubert Scharnagl, et al.. (2016). Klinische Bedeutung des HDL-Cholesterins. Herz. 42(1). 58–66. 7 indexed citations
17.
Zewinger, Stephen, et al.. (2015). Innate immunity in CKD-associated vascular diseases. Nephrology Dialysis Transplantation. 31(11). 1813–1821. 36 indexed citations
18.
Zewinger, Stephen, Thimoteus Speer, Marcus E. Kleber, et al.. (2014). HDL Cholesterol Is Not Associated with Lower Mortality in Patients with Kidney Dysfunction. Journal of the American Society of Nephrology. 25(5). 1073–1082. 74 indexed citations
19.
Shroff, Rukshana, Thimoteus Speer, Sophie Colin, et al.. (2014). HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype. Journal of the American Society of Nephrology. 25(11). 2658–2668. 88 indexed citations
20.
Speer, Thimoteus, Erik W. Holy, Stephen Zewinger, et al.. (2014). Carbamylated low-density lipoprotein induces endothelial dysfunction. European Heart Journal. 35(43). 3021–3032. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026